Global Immunodiagnostics Market, By Product (Reagents, Instruments, and Software and Services), Technology (Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test and Others), Application (Infectious Diseases, Oncology and Endocrinology, Hepatitis and Retrovirus, Bone and Mineral, Autoimmunity, Cardiac Biomarker and Others), End User (Clinical Laboratories, Hospitals, Academic and Research Centers, Pharmaceutical and Biotechnology Industry, Others) - Industry Trends and Forecast to 2030.
Immunodiagnostics Market Analysis and Size
Major factors expected to boost the growth of the immunodiagnostics market in the forecast period are the increase in the prevalence of infectious diseases, cardiovascular diseases, cancer, gastrointestinal, and other chronic diseases, the rising geriatric population and variations in the demographics and lifestyle. Furthermore, the scientific development in diagnosis kits, assays and analyzers and the rise in the alertness of the preventive health measures amongst patients and medical professionals are a few of the factors anticipated to further propel the growth of the immunodiagnostics market. However, the strict governing scenarios are one of the factors further estimated to impede the growth of the immunodiagnostics market in the near future.
Data Bridge Market Research analyses that the Immunodiagnostics market which was USD 16.87 Billion in 2022, would rocket up to USD 36.54 Billion by 2030, and is expected to undergo a CAGR of 12.8% during the forecast period. This indicates that the market value. “Instruments” dominates the product segment of the Immunodiagnostics market owing to the technological advancements in immunoassay techniques. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Immunodiagnostics Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2016-2021) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product (Reagents, Instruments, and Software and Services), Technology (Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test and Others), Application (Infectious Diseases, Oncology and Endocrinology, Hepatitis and Retrovirus, Bone and Mineral, Autoimmunity, Cardiac Biomarker and Others), End User (Clinical Laboratories, Hospitals, Academic and Research Centers, Pharmaceutical and Biotechnology Industry, Others) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) |
|
Market Players Covered |
Omega Diagnostics Group PLC – (United Kingdom), Nexus-Dx – (United States), Protagen Protein Services GmbH – (Germany), Quest Diagnostics Incorporated – (United States), Seramun Diagnostica GmbH –( Germany), SQI Diagnostics –( Canada), Tecan Trading AG – (Switzerland), Siemens – (Germany), DiaSorin S.p.A. – (Italy), Erba Diagnostics – (United States), Svar Life Science AB – (Sweden), Exagen Inc. – (United States), Abbott – (United States), F. Hoffmann-La Roche Ltd – (Switzerland), Danaher – (United States), Adaptive Biotechnologies – (United States), QIAGEN – (Netherlands), AMARANTUS BIOSCIENCE HOLDINGS, INC. – (United States), AESKU.GROUP GmbH – (Germany), Avant Diagnostics, Inc. –( United States) |
|
Market Opportunities |
|
Market Definition
Immunodiagnostics is a branch of in vitro diagnostics that diagnoses the disease based on antigen antibody reactions. It is utilized for diagnosing infectious diseases and chronic diseases like cancers, autoimmune disorders, and others. It is utilized in the field of cardiovascular diseases, infectious diseases, autoimmune disorders, endocrinology, oncology, and amongst others.
Global Immunodiagnostics Market Dynamics
Drivers
- Increasing Prevalence of Chronic and Infectious Diseases
The rising incidence of chronic diseases such as cancer, autoimmune disorders, and infectious diseases is driving the demand for immunodiagnostics. These tests play a crucial role in the accurate and early detection of diseases.
- Technological Advancements in Immunoassay Techniques
The continuous advancements in immunoassay technologies, such as chemiluminescence immunoassay (CLIA) and enzyme-linked immunosorbent assay (ELISA), have improved the sensitivity, specificity, and efficiency of immunodiagnostics, driving the market growth.
Opportunities
- Advancements in Biomarker Discovery
Ongoing research and development activities are focused on identifying new biomarkers for various diseases. The discovery of novel biomarkers creates opportunities for the development of new immunodiagnostic tests.
- Expansion in Emerging Markets
The increasing healthcare infrastructure and rising healthcare expenditure in emerging markets present significant growth opportunities for immunodiagnostics. These regions offer untapped market potential and a growing patient population.
Restraints
- High Cost of Immunodiagnostics
The high cost associated with immunodiagnostic tests and instruments may limit their adoption, particularly in developing regions with limited healthcare budgets. Affordability and cost-effectiveness remain challenges for market growth.
- Stringent Regulatory Requirements
The stringent regulatory framework and approval processes for immunodiagnostics pose challenges for market players. Compliance with regulations and obtaining necessary approvals can be time-consuming and expensive.
Challenges
- Technical Limitations and False Results
Despite advancements, certain technical limitations, including cross-reactivity, interference, and false-positive or false-negative results, remain challenges in immunodiagnostics. Ensuring test accuracy and reliability is crucial.
This immunodiagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the immunodiagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In September 2022, Mindray launched the ToRCH Panel. With this panel, the company offers high-quality assays to meet different clinical needs. Mindray ToRCH kits support diverse sample types with low quality control and volume, which ensures significant ease and convenience during clinical detection
- In May 2022, Thermo Fisher Scientific announced that the Phadia 2500+ series of instruments are available for autoimmune testing in the US. The family of high-capacity, intuitive lab instruments supplied by Thermo Fisher Scientific—the world leader in serving science offers reliable and unparalleled high throughput for allergy diagnostics and autoimmune testing.
Global Immunodiagnostics Market Scope
The immunodiagnostics market is segmented on the basis of product, technology, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications.
Product
- Reagents
- Instruments
- Software And Services
Technology
- Enzyme-linked immunosorbent assay
- Chemiluminescence immunoassay
- Fluorescent immunoassay
- Radioimmunoassay
- Rapid test
- Others
Application
- Infectious diseases
- Oncology and endocrinology
- Hepatitis and retrovirus
- Bone and mineral
- Autoimmunity
- Cardiac biomarker
- Others.
End User
- Clinical laboratories
- Hospitals
- Academic and Research Centres
- Pharmaceutical and Biotechnology Industry
- Others.
Immunodiagnostics Market Regional Analysis/Insights
The immunodiagnostics market is analysed and market size insights and trends are provided by country, product, technology, application and end user, as referenced above.
The countries covered in the immunodiagnostics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to dominate the immunodiagnostics market because of the increase in the demand for immunodiagnostics tests, the rise in the elderly population, and increasing incidences of chronic and infectious diseases. Furthermore, the increase in alertness amongst the customers related to early disease management, which would encourage them to undergo regular tests and check-ups will further boost the growth of the immunodiagnostics market in the region during the forecast period.
Asia Pacific is projected to witness a significant amount of growth in the forecast period of 2023 to 2030 immunodiagnostics market because of the increase in the investments by various key players, rise in the consciousness, progress in the health care infrastructure, and suitable governing reforms, moreover, because of the prevalence of the huge population pool with high clinical unmet need which is further anticipated to propel the growth of the immunodiagnostics market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The immunodiagnostics market also provides you with detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the Immunodiagnostics market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the Immunodiagnostics market. The data is available for the historic period 2010-2020.
Competitive Landscape and Immunodiagnostics Market Share Analysis
The Immunodiagnostics market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the immunodiagnostics market.
Some of the major players operating in the immunodiagnostics market are:
- Omega Diagnostics Group PLC - United Kingdom
- Nexus-Dx - United States
- Protagen Protein Services GmbH - Germany
- Quest Diagnostics Incorporated - United States
- Seramun Diagnostica GmbH - Germany
- SQI Diagnostics - Canada
- Tecan Trading AG - Switzerland
- Siemens - Germany
- DiaSorin S.p.A. - Italy
- Erba Diagnostics - United States
- Svar Life Science AB - Sweden
- Exagen Inc. - United States
- Abbott - United States
- F. Hoffmann-La Roche Ltd - Switzerland
- Danaher - United States
- Adaptive Biotechnologies - United States
- QIAGEN - Netherlands
- AMARANTUS BIOSCIENCE HOLDINGS, INC. - United States
- AESKU.GROUP GmbH - Germany
- Avant Diagnostics, Inc. - United States
SKU-
